Potassium Iodide (KI) Articles

  2004-2005 President Paul W. Ladenson, M.D. Baltimore, Maryland Secretary Gregory A. Brent, M.D. Los Angeles, California Treasurer Charles H. Emerson, M.D. Worcester, Massachusetts President-Elect Ernest L. Mazzaferri, M.D. Gainesville, Florida Directors Stephanie L. Lee, M.D., Ph.D. (2005) Boston, Massachusetts John C. Morris, III, M.D. (2005) Rochester, Minnesota Alan P. Farwell, M.D. (2005) Worcester, Massachusetts Rebecca S. Bahn, M.D. (2006) Rochester, Minnesota Donald L. St. [...]

NAS Study Panel recommendations on KI

An Assessment of Federal and State Guidelines for the Distribution of Potassium Iodide in the Event of a Nuclear Accident or Nuclear Terrorism.  Download Statement (PDF File, 72 KB)

Experts Discuss Potassium Iodide Distribution in Case of Nuclear Incident Download Statement

American Thyroid Association Endorses Potassium Iodide for Radiation Emergencies November 7, 2001; most recent update July 24, 2002 This statement is supported by the American Association of Clinical Endocrinologists, the Lawson Wilkins Pediatric Endocrine Society, and the Thyroid Foundation of America. The American Thyroid Association (ATA) endorses the use of potassium iodide (KI) to protect people from absorbing radioactive iodine released during a nuclear emergency. [...]

By Peter G. Crane, AttorneyReprinted from the Seattle Post-IntelligencerThursday, February 14, 2002 In the wake of Sept. 11, the federal government has taken an important step to improve the protection of the public against acts of nuclear terrorism. Three agencies have played key roles. The Department of Health and Human Services announced that it was buying millions of doses of the anti-radiation drug potassium iodide, [...]